Skip to main content
GNTA
NASDAQ Life Sciences

Genenta Science Seeks Shareholder Approval for Massive Capital Raise, Reverse Split, and Name Change

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$1.83
Mkt Cap
$43.818M
52W Low
$0.55
52W High
$10
52W Position info
233% above low
Off High info
82% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

GNTA has more than doubled off its 52-week low of $0.55 on light trading volume (0.3× avg).

Summary

Genenta Science is seeking shareholder approval for a massive capital raise authorization, a reverse stock split, a corporate name change to Saentra Forge S.p.A., and will face a contested Board of Directors election at its upcoming meeting.


Key Events · Financing and Capital Events · GNTA

  • Massive Capital Raise Authorization Proposed

    Shareholders will vote on delegating authority to the Board to increase share capital and/or issue convertible bonds up to Euro 300,000,000, involving up to 120,000,000 new ordinary shares, over a five-year period. This potential capital raise significantly exceeds the company's current market capitalization.

  • Reverse Stock Split Proposed

    Shareholders will vote on a proposed reverse stock split to help maintain Nasdaq listing compliance. The Board will have discretion on the exact ratio and timing, following a recent Nasdaq deficiency notice.

  • Corporate Name Change to Saentra Forge S.p.A.

    A proposal to change the company's corporate name to Saentra Forge S.p.A. will be voted on, reflecting a strategic pivot, particularly after recent acquisitions in the aerospace sector.

  • Contested Board of Directors Election

    Two alternative slates of candidates have been submitted for the Board of Directors, indicating a potential proxy contest following recent activist investor activity.


Analysis · GNTA · Life Sciences

Genenta Science is seeking shareholder approval for several critical measures that could fundamentally reshape its financial structure and strategic direction. The proposed authorization for a capital increase of up to Euro 300 million, which is many times its current market capitalization, signals a potential for extreme dilution for existing shareholders if fully utilized. This comes alongside a proposed reverse stock split, a common measure for companies struggling with low share prices and Nasdaq compliance, despite recently regaining compliance. The planned corporate name change to Saentra Forge S.p.A. confirms a significant strategic pivot, moving away from its original "Science" focus towards its new aerospace acquisitions. Furthermore, the submission of two alternative slates for the Board of Directors suggests ongoing governance challenges and shareholder activism. These combined factors indicate a period of significant uncertainty and potential financial strain for the company.

At the time of this filing, GNTA was trading at $1.83 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $43.8M. The 52-week trading range was $0.55 to $10.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

GNTA - Latest Insights

GNTA
Jul 14, 2026, 4:04 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.25
Real-time Price: $1.53 info
Change: +$0.280 (+22%) info
Market Cap: $36.789M info
GNTA
Jul 01, 2026, 4:09 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $1.77
Real-time Price: $1.53 info
Change: -$0.240 (-14%) info
Market Cap: $36.789M info
GNTA
Jun 26, 2026, 4:05 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.82
Real-time Price: $1.53 info
Change: -$0.290 (-16%) info
Market Cap: $36.789M info
GNTA
Jun 24, 2026, 9:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.84
Real-time Price: $1.53 info
Change: -$0.3124 (-17%) info
Market Cap: $36.789M info
GNTA
Jun 16, 2026, 9:15 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.76
Real-time Price: $1.53 info
Change: -$0.230 (-13%) info
Market Cap: $36.789M info